DEVELOPMENT OF NOVEL NANOTHERAPEUTICS TO COMBAT PNEUMONIC PLAGUE
Agency: | DEPT OF DEFENSE |
---|---|
Level of Government: | Federal |
Category: |
|
Opps ID: | NBD00159933008489838 |
Posted Date: | Mar 9, 2023 |
Due Date: | Mar 23, 2023 |
Solicitation No: | HT9425-23-KKL-0002 |
Source: | https://sam.gov/opp/d5274ab6fc... |
Procurement Technical Assistance Centers (PTACs) are an official government contracting resource for small businesses. Find your local PTAC (opens in new window) for free government expertise related to contract opportunities.
- Contract Opportunity Type: Sources Sought (Original)
- All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
- Original Published Date: Mar 09, 2023 03:26 pm EST
- Original Response Date: Mar 23, 2023 01:00 pm EDT
- Inactive Policy: 15 days after response date
- Original Inactive Date:
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AJ12 - General Science and Technology R&D Services; General science and technology; Applied Research
-
NAICS Code:
- 541713 - Research and Development in Nanotechnology
-
Place of Performance:
Frederick , MD 21702USA
The Government intends to award an Indefinite Delivery/Indefinite Quantity (IDIQ) contract for novel nanotherapeutic approaches targeting outer membrane proteins for the treatment of pneumonic plague (and potentially other infectious microbial organisms or toxins) for assessment in in vitro and in vivo assays support. These services include, but are not limited to production of high-quality recombinant proteins from bacteria, viruses, or toxins; vaccinating appropriate animal species (i.e. camelids and bovines) to generate the material needed to engineer completely novel nanotherapeutics; perform in vitro testing of nanotherapeutic characteristics in order to refine molecules and promote down-selection, provide material in sufficient quantity and appropriate quality for in vitro and in vivo studies (e.g. mice and non-human primates), engineer or formulate down-selected nanotherapeutics for different routes of administration in vivo (e.g., intramuscular or intravenous, etc.).
- BLDG 820 PBO 820 CHANDLER STREET
- FORT DETRICK , MD 21702-5014
- USA
- Shelley Wallace
- Shelley.a.wallace2.civ@health.mil
- Kristen Lawrence
- kristen.k.lawrence.civ@health.mil
- Mar 09, 2023 03:26 pm ESTSources Sought (Original)
TRY FOR FREE
Not a USAOPPS Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.